FibroGen, Inc. (FGEN)

R&D Expense Growth

-9.85%

Quarterly · Period ending:

FGEN logo

FGEN R&D Expense Growth

Latest reported-9.85%
FGEN Quarterly R&D Growth (QoQ) (0.00% → -9.85%)
High-resolution chart · PNG

FGEN r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

FibroGen, Inc. R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
-9.8467%
4.1002%
501.158%
-79.3862%
-36.0763%
517.4293%
-93.1546%
-32.9172%
-11.3157%
-29.4258%
-15.5097%
-35.9077%
28.1825%
20.8639%
-18.0283%
5.9454%
-20.2824%
-21.8592%
50.1318%
-38.091%
64.1317%
-4.4233%
33.6138%
-4.7839%
11.8611%
-3.3364%
13.6781%
-3.9321%
2.9943%
-28.1543%
24.5221%
8.2569%
-8.4881%
8.586%
4.2375%
7.1412%
0.5328%
-7.657%
24.7769%
-22.5874%
20.0275%
-27.1577%
15.0813%
1.0009%
2.0103%
-1.4027%
26.1984%
22.0866%
29.7037%
-12.8559%
26.9582%
28.6356%
19.6032%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.